van Hulst M[au] - Search Results

Year	Number of Results
1985	1
2002	1
2003	1
2005	4
2006	1
2008	1
2009	3
2010	2
2012	2
2013	3
2014	1
2015	2
2016	5
2017	7
2018	5
2019	5
2020	4
2021	5
2022	4
2023	0

1

Progress on the elimination of viral hepatitis in Zimbabwe: A review of the policies, strategies and challenges.

Dzingirai B, Katsidzira L, Matyanga CMJ, Postma MJ, van Hulst M, Mafirakureva N. Dzingirai B, et al. Among authors: van hulst m. J Viral Hepat. 2021 Jul;28(7):994-1002. doi: 10.1111/jvh.13510. Epub 2021 Apr 9. J Viral Hepat. 2021. PMID: 33797190 Free PMC article. Review.

2

Health economics of blood transfusion safety--focus on sub-Saharan Africa.

van Hulst M, Smit Sibinga CT, Postma MJ. van Hulst M, et al. Biologicals. 2010 Jan;38(1):53-8. doi: 10.1016/j.biologicals.2009.10.006. Epub 2009 Dec 21. Biologicals. 2010. PMID: 20022523 Free article. Review.

3

Unintentional ingestion of a high dose of acenocoumarol in a young child.

Brands MR, Sytema J, van Hulst M, Kamps AW. Brands MR, et al. Among authors: van hulst m. BMJ Case Rep. 2021 Apr 1;14(4):e240365. doi: 10.1136/bcr-2020-240365. BMJ Case Rep. 2021. PMID: 33795273 Free PMC article.

4

Cost-effectiveness analysis of quadrivalent and nonavalent human papillomavirus vaccines in Ethiopia.

Wondimu A, Postma MJ, van Hulst M. Wondimu A, et al. Among authors: van hulst m. Vaccine. 2022 Mar 25;40(14):2161-2167. doi: 10.1016/j.vaccine.2022.02.080. Epub 2022 Mar 2. Vaccine. 2022. PMID: 35248423 Free article.

5

Economic evaluations of hepatitis B vaccination for developing countries.

Tu HA, Woerdenbag HJ, Kane S, Riewpaiboon A, van Hulst M, Postma MJ. Tu HA, et al. Among authors: van hulst m. Expert Rev Vaccines. 2009 Jul;8(7):907-20. doi: 10.1586/erv.09.53. Expert Rev Vaccines. 2009. PMID: 19538116 Review.

6

Pharmaco-economics of blood transfusion safety: review of the available evidence.

van Hulst M, de Wolf JT, Staginnus U, Ruitenberg EJ, Postma MJ. van Hulst M, et al. Vox Sang. 2002 Aug;83(2):146-55. doi: 10.1046/j.1423-0410.2002.00198.x. Vox Sang. 2002. PMID: 12201844 Review.

7

Health economic evaluation of nation-wide screening programmes for atrial fibrillation in the Netherlands.

van Hulst M, Tieleman RG, Zwart LAR, Pomp M, Jacobs MS, Meeder JG, van Ofwegen-Hanekamp CEE, Hollander M, Smits P, Hemels MEW. van Hulst M, et al. Eur Heart J Qual Care Clin Outcomes. 2022 Jul 26:qcac042. doi: 10.1093/ehjqcco/qcac042. Online ahead of print. Eur Heart J Qual Care Clin Outcomes. 2022. PMID: 35881482

8

Correction: Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in the real-world and trial settings.

de Jong LA, Groeneveld J, Stevanovic J, Rila H, Tieleman RG, Huisman MV, Postma MJ, van Hulst M. de Jong LA, et al. Among authors: van hulst m. PLoS One. 2022 Mar 31;17(3):e0266625. doi: 10.1371/journal.pone.0266625. eCollection 2022. PLoS One. 2022. PMID: 35358286 Free PMC article.

9

Cost-effectiveness of screening smokers and ex-smokers for lung cancer in the Netherlands in different age groups.

Al Khayat MNMT, Eijsink JFH, Postma MJ, van de Garde EMW, van Hulst M. Al Khayat MNMT, et al. Among authors: van hulst m. Eur J Health Econ. 2022 Sep;23(7):1221-1227. doi: 10.1007/s10198-021-01422-w. Epub 2022 Jan 5. Eur J Health Econ. 2022. PMID: 34985584 Free PMC article.

10

Inequalities in Rotavirus Vaccine Uptake in Ethiopia: A Decomposition Analysis.

Wondimu A, van der Schans J, van Hulst M, Postma MJ. Wondimu A, et al. Among authors: van hulst m. Int J Environ Res Public Health. 2020 Apr 14;17(8):2696. doi: 10.3390/ijerph17082696. Int J Environ Res Public Health. 2020. PMID: 32295233 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results